eFFECTOR Therapeutics, Inc. (EFTR) Social Stream

eFFECTOR Therapeutics, Inc. (EFTR): $6.42

-0.23 (-3.46%)

POWR Rating

Component Grades













Add EFTR to Watchlist
Sign Up

Industry: Biotech


of 459

in industry

eFFECTOR Therapeutics Inc (EFTR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering eFFECTOR Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $50 $20 $30.75 $5.71 438.53%

EFTR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EFTR as an investment opportunity.

  • eFFECTOR Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 96.96% of all US stocks.
  • The variance in analysts' estimates of EFTR is lower than 6.42% of all US stocks.
  • The number of analysts covering the stock of EFTR is higher than 27.3% of all US stocks.
  • eFFECTOR Therapeutics Inc's average analyst price target is greater than 69.49% of stocks in the small market cap category.

Stocks similar to eFFECTOR Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EIGR, HTBX and MNOV.

What is the outlook for EFTR? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7246 seconds.